What is William Blair's Estimate for InnovAge Q2 Earnings?

Key Points

• William Blair estimates InnovAge's Q2 2026 earnings at $0.04 per share, with full-year earnings expected to reach $0.15 per share.
• InnovAge's recent earnings report indicated a loss of ($0.01) per share, better than the consensus estimate of ($0.02).
• The company's stock has a market capitalization of $626.66 million and has shown a 52-week range between $2.60 and $6.69.

InnovAge Holding Corp. (NASDAQ:INNV - Free Report) - Analysts at William Blair issued their Q2 2026 earnings estimates for InnovAge in a research report issued on Wednesday, September 10th. William Blair analyst J. Haase expects that the company will post earnings per share of $0.04 for the quarter. The consensus estimate for InnovAge's current full-year earnings is ($0.12) per share. William Blair also issued estimates for InnovAge's Q3 2026 earnings at $0.05 EPS, Q4 2026 earnings at $0.07 EPS, FY2026 earnings at $0.15 EPS and FY2027 earnings at $0.23 EPS.

InnovAge (NASDAQ:INNV - Get Free Report) last released its quarterly earnings results on Tuesday, September 9th. The company reported ($0.01) EPS for the quarter, beating analysts' consensus estimates of ($0.02) by $0.01. InnovAge had a negative net margin of 3.55% and a negative return on equity of 12.02%. The company had revenue of $221.42 million for the quarter, compared to analyst estimates of $219.80 million. InnovAge has set its FY 2026 guidance at EPS.

InnovAge Stock Performance

Shares of NASDAQ:INNV traded up $0.09 during trading on Friday, reaching $5.27. The stock had a trading volume of 30,547 shares, compared to its average volume of 45,615. InnovAge has a 52 week low of $2.60 and a 52 week high of $6.69. The firm has a market capitalization of $714.69 million, a price-to-earnings ratio of -22.54 and a beta of 0.52. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.27. The stock has a fifty day simple moving average of $3.84 and a two-hundred day simple moving average of $3.60.

Hedge Funds Weigh In On InnovAge

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Barclays PLC increased its position in InnovAge by 13.6% during the fourth quarter. Barclays PLC now owns 29,099 shares of the company's stock worth $115,000 after acquiring an additional 3,485 shares during the period. Charles Schwab Investment Management Inc. increased its position in InnovAge by 2.8% during the first quarter. Charles Schwab Investment Management Inc. now owns 164,322 shares of the company's stock worth $490,000 after acquiring an additional 4,535 shares during the period. Bank of America Corp DE increased its position in InnovAge by 42.4% during the fourth quarter. Bank of America Corp DE now owns 19,945 shares of the company's stock worth $78,000 after acquiring an additional 5,936 shares during the period. Jane Street Group LLC increased its position in InnovAge by 18.9% during the first quarter. Jane Street Group LLC now owns 46,827 shares of the company's stock worth $140,000 after acquiring an additional 7,429 shares during the period. Finally, Police & Firemen s Retirement System of New Jersey bought a new position in InnovAge during the second quarter worth $32,000. Institutional investors own 12.26% of the company's stock.

About InnovAge

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.